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INTRODUCTION
The reported prevalence of stress urinary incontinence (SUI) in 
men is high and increases with age [1]. When conservative 
treatments like pelvic floor muscle training fail, a surgical ap-
proach is recommended [2]. Due to its high success rates in the 
treatment of male SUI, the artificial urinary sphincter (AUS) is 
still the standard treatment for persistent moderate to severe 
SUI [2,3]. Nowadays, the AMS 800 device (Boston Scientific, 
formerly AMS, Minnetonka, MN, USA) is most commonly 
used, even though there are alternative devices available [4]. 
However, revision rates for nonmechanical reasons such as ero-
sion, urethral atrophy, and infections range from 7% to 17% [5-
8]. In addition, manual dexterity and sufficient mental function 
is necessary to handle the AUS properly. Several readjustable 
male slings have been introduced in recent years and patient 
demand for slings is high [9]. The Argus classic system (Prome-
don, Cordoba, Argentina) is a radiopaque cushioned system 
with a silicone foam pad for soft compression of the bulbar ure-
thra and is implanted via a retropubical approach [10]. The Ar-
gus T sling system (Promedon) was launched in 2008 and dif-
fers in terms of implantation route (transobturatoric approach) 
and the position of the washers [11]. 
 Since we are still lacking prospective comparative trials in-
vestigating different surgical devices, the “Debates on Male In-
continence” (DOMINO) working group aims to provide large 
comparative multicenter studies providing robust data on daily 
routine at various Central European continence centers. In ad-
dition, evidence is currently based on case series from a few 
high-volume centers. However, in Central Europe, occasional 
implanters implant a significant proportion of devices. In the 
current study, we compare perioperative complications as well 
as short-term explantation rates of some of the most commonly 
used adjustable male sling systems with the current gold stan-
dard, the perineal single-cuff AUS in a large retrospective, in-
ternational, multicenter comparative study.
MATERIALS AND METHODS
Patient Population
Inclusion criteria in the current study were as follows: verified 
nonneurogenic SUI, moderate or severe SUI (defined as daily 
pad usage of ≥3), and implantation of an Argus classic male 
sling, Argus T male sling, or perineal single-cuff AMS 800 AUS. 
In total, 282 patients from 13 different institutions were included.
Purpose: To analyze perioperative complications and postoperative explantation rates for selected readjustable male sling sys-
tems and the perineal single-cuff artificial urinary sphincter (AUS) in a large, contemporary, multi-institutional patient cohort.
Methods: Two hundred eighty-two male patients who underwent implantation between 2010 and 2012 in 13 participating in-
stitutions were included in the study (n=127 adjustable male sling [n=95 Argus classic, n=32 Argus T], n=155 AUS). Peri-
operative characteristics and postoperative complications were analyzed. The explantation rates of the respective devices were 
assessed using the Fisher exact test and the Mann-Whitney U-test. A Kaplan-Meier curve was generated. Potential features as-
sociated with device explantation were analyzed using a multiple logistic regression model (P<0.05). 
Results: We found significantly increased intraoperative complication rates after adjustable male sling implantation (15.9% [ad-
justable male sling] vs. 4.2% [AUS], P=0.003). The most frequent intraoperative complication was bladder perforation (n=17). 
Postoperative infection rates did not vary significantly between the respective devices (P=0.378). Device explantation rates 
were significantly higher after AUS implantation (9.7% [adjustable male sling] vs. 21.5% [AUS], P=0.030). In multivariate anal-
ysis, postoperative infection was a strong independent predictor of decreased device survival (odds ratio, 6.556; P=0.001). 
Conclusions: Complication profiles vary between adjustable male slings and AUS. Explantation rates are lower after adjust-
able male sling implantation. Any kind of postoperative infections are independent predictors of decreased device survival. 
There is no significant effect of the experience of the implanting institution on device survival.
Keywords: Urinary Incontinence, Stress; Urinary Sphincter, Artificial; Complications
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Study Design and Data Assessment
The study was approved by a local ethics committee. Data col-
lection was performed retrospectively by external independent 
physicians who were not members of the implanting center. 
 Perioperative complications were defined as any complica-
tions occurring within the first 6 months postoperatively. Ana-
lyzed perioperative complications included bleeding, wound 
healing disorders, acute urinary retention, infection, and pro-
longed perineal pain (lasting more than 6 weeks postoperative-
ly). Infection was defined as any recorded infection due to clini-
cal presentation (fever, local tenderness, erythema, skin fixa-
tion, abscess, pathologic urinary test results) not including pri-
mary device infections. Acute urinary retention was defined as 
the complete inability to void. In addition, device explantation 
rates were assessed. Furthermore, in order to define potential 
features associated with device explantation, multiple hypothe-
sized patient- and procedure-derived risk factors were tested.
Patient Selection
Due to the retrospective study design, patient selection within 
the respective groups was not standardized. Instead, the follow-
ing basic operating principles were used. All included patients 
were considered not to be suitable for a retrourethral transobtu-
rator male sling based on the medical history, volume of urine 
leakage, existence of nocturnal incontinence, or a failed ure-
throcystoscopic repositioning test [12]. Patients who were not 
physically or mentally able to handle the AUS were automati-
cally offered an adjustable male sling. If patients were consid-
ered to be able to handle the AUS properly, they were offered 
the option of either an adjustable male sling or an AUS. The fi-
nal decision was then mostly based on the patient’s decision as 
well as on the expertise of the treating physician. 
Statistical Analysis
The primary endpoint was the perioperative complication rate 
as well as device explantation rate after adjustable male sling 
and AUS implantation. For categorical data, the Fisher exact 
test and chi-square test were used. For continuous data, the 
Wilcoxon rank sum test was performed. Univariate analysis 
was performed to test for potential predictive features for device 
explantation. Additionally, a multivariate analysis using a mul-
tiple logistic regression model was performed. To further dis-
play potential differences in explantation rates, a Kaplan-Meier 
curve was generated. All statistical analyses as well as graphics 
were created using IBM SPSS Statistics ver. 23.0 (IBM Co., Ar-
monk, NY, USA). A P-value <0.05 was considered to be statis-
tically significant. 
RESULTS
Pre- and Perioperative Patient Characteristics and 
Perioperative Standard Procedures
Table 1 summarizes the baseline characteristics of 282 consecu-
tive patients (n=127 adjustable male sling [n=95 Argus classic, 
n=32 Argus T], n=155 AUS) that were included in the study. 
Briefly, patients undergoing adjustable male sling implantation 
were less likely to undergo salvage surgery (21.3% vs. 38.1%, 
P=0.003) and less likely to have a history of bladder neck stric-
ture (5.5% vs. 12.9%, P=0.042) compared to patients who un-
derwent AUS implantation.
 Every patient received intraoperative antibiotic prophylaxis. 
Antibiotic prophylaxis was started one day preoperatively in 
27.3% of the cases (7.9% [adjustable male sling] vs. 43.2% 
[AUS], P<0.001). An intraoperative single-shot antibiotic pro-
phylaxis was administered in 8.2% of all patients (14.2% [ad-
justable male sling] vs. 3.2% [AUS], P<0.001). 
Perioperative Complications and Explantation Rates
To improve the ability to generalize our results, perioperative 
complication rates of the respective devices were analyzed in a 
selected subgroup of our patient cohort. The median number of 
device implantations per institution in our study cohort was 
found to be 20.5 (range, 1–52). Consequently, the participating 
centers were divided into less-experienced centers ( ≤20 im-
plantations between 2010 and 2012; defined as “low-volume”) 
and more experienced centers (>20 implantations; defined as 
“high-volume”). Implantations that had been performed by a 
less-experienced center (n=49) were excluded from this partic-
ular analysis. 
 Perioperative complications and explantation rates after ad-
justable male sling and AUS implantation of the remaining pa-
tient cohort are summarized in Table 2. We found significantly 
increased intraoperative complication rates after adjustable 
male sling implantation (15.9% [adjustable male sling] vs. 4.2% 
[AUS], P=0.004). The most frequent intraoperative complica-
tion was bladder perforation (n=17). Postoperative infection 
rates did not vary significantly between the respective devices 
(P=0.378). The most frequently observed infections were uri-
nary tract infections (n =6), followed by wound infections 
(n=3), and fever without an apparent focus (n=2).
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 Follow-up data concerning explantation rates were available 
for 207 of 233 patients (88.8%).  Device explantation rates were 
significantly higher after AUS implantation (9.7% [adjustable 
male sling] vs. 21.5% [AUS], P=0.030). A Kaplan-Meier sur-
Table 1. Patient characteristics of 282 patients that were included in the current study.    
Characteristic Adjustable male sling AUS Total P-value
No. of patients 127 (45.0) 155 (55.0) 282 (100) -
Age (yr) 70.0±6.9 69.4±10.9 69.7±9.4 0.601
Body mass index (kg/m2) 27.4±3.3 27.7±4.1 27.5±3.6 0.730
Salvage surgery 27 (21.3) 59 (38.1) 86 (30.5) 0.003*
Pelvic radiation 35 (27.6) 36 (23.2) 71 (25.2) 0.412
Urethral stricture 21 (16.5) 39 (25.2) 60 (21.3) 0.082
Bladder neck stricture 7 (5.5) 20 (12.9) 27 (9.6) 0.042*
Diabetes mellitus 29 (22.8) 28 (18.1) 57 (20.2) 0.372
Etiology of SUI
   PPI
   TURP
   Other
  
110 (86.6)
14 (11.0)
3 (2.4)
  
127 (81.9)
24 (15.5)
4 (2.6)
  
237 (84.3)
38 (13.5)
7 (2.5)
  
0.250
0.316
1.000
Grade of SUI 
   Moderate
   Severe
  
82/115 (71.3)
33/115 (28.7)
  
62/96 (64.6)
34/96 (35.4)
  
144/211 (68.2)
67/211 (31.8)
  
0.303
0.303
Pads per 24 hr 5.9±2.6 6.9±3.3 6.3±3.5 0.198
Values are presented as number (%) or mean±standard deviation.    
AUS, artificial urinary sphincter; SUI, stress urinary incontinence; PPI, postprostatectomy incontinence; TURP, transurethral resection of the pros-
tate.    
*P<0.05, statistically significant.    
Table 2. Perioperative complication rates after 233 device implantations in high-volume (>20 implantations in the study cohort) centers 
Variable Adjustable male slings AUS Total P-value
No. of patients 113 (48.5) 120 (51.5) 233 (100) -
Intraoperative complications 18 (15.9) 5 (4.2) 23 (9.9) 0.004*
Postoperative bleeding 2 (1.8) 5 (4.2) 7 (3.0) 0.276
Postoperative wound healing disorder 2 (1.8) 4 (3.3) 6 (2.6) 0.442
Postoperative urinary retention 11 (9.7) 13 (10.8) 24 (10.3) 0.670
Prolonged perineal pain 17 (15.0) 9 (7.5) 26 (11.2) 0.095
Postoperative infection 4 (3.5) 8 (6.7) 12 (5.2) 0.378
Device explantationa) 11 (9.7) 20 (21.5) 31/207 (15.0) 0.030*
Reasons for device explantation
Persistent SUI
Device infection
Urethral erosion
Mechanical device failure
Persistent urinary retention
Other
  
3 (2.7)
1 (0.9)
1 (0.9)
0 (0)
1 (0.9)
2 (1.8)
  
4 (3.3)
6 (5.0)
6 (5.0)
3 (2.5)
0 (0)
1 (0.8)
  
7 (3.0)
7 (3.0)
7 (3.0)
3 (1.3)
1 (0.4)
3 (1.3)
  
0.533
0.070
0.070
0.135
0.485
0.612
Time to explantation (day) 216.8±172.8 179.2±165.4 189.3±165.9 0.533
Values are presented as number (%) or mean±standard deviation.    
AUS, artificial urinary sphincter; SUI, stress urinary incontinence.    
a)Total n=207 due to lost-to-follow-up patients. *P<0.05, statistically significant.    
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vival curve was generated (Fig. 1). We performed a separate 
subgroup analysis within the adjustable male sling group and 
compared perioperative complication rates after Argus classic 
and after Argus T implantation. We found that all intraopera-
tive complications occurred during Argus classic implantation 
(P=0.006). Perineal pain occurred significantly more frequent-
ly after Argus T implantation (4.7 [Argus classic] vs. 46.4% [Ar-
gus T], P<0.001). 
Risk Factors for Device Explantation
We next evaluated various predefined patient- and procedure-
derived features that were hypothesized to contribute to in-
creased device explantation rates. To address the potential im-
pact of the experience of the implanting center, high-volume as 
well as low-volume centers were included in the analysis. 
 Results of the univariate analysis are summarized in Table 3. 
No significant impact of preoperative age, BMI, or preoperative 
grade of SUI based on daily pad use was observed (P=0.474, 
P=0.090, P=0.462, respectively). 
 Based on the results of the univariate analysis, a multivariate 
analysis was performed using a multiple logistic regression 
model. Hereby, all features showing significant results in the 
univariate analysis, the respective devices and the experience of 
the implanting centers were included. 
 The results of the multivariate analysis are summarized in 
Table 4. To summarize, any kind of postoperative infection was 
a strong independent predictor of decreased device survival 
(odds ratio [OR], 6.559; P=0.001), and there was a trend to-
Table 4. Summary of the multivariate analysis using a binary logistic regression model, indicating any kind of postoperative infections 
being independent prognostic features for increased device explantation rates    
Predictive feature SE P-value Odds ratio 95% CI
Artificial urinary sphincter 0.424 0.074 2.615 1.138–6.009
Bladder neck stricture 0.544 0.361 1.644 0.566–4.779
Postoperative infection 0.592 0.001 6.559 2.055–20.934
High-volume centre 0.455 0.615 0.795 0.326–1.941
SE, standard error; CI, confidence interval.    
Table 3. Univariate analysis of predefined hypothesized predic-
tive features for increased or decreased device explantation rates 
Predictive feature Device explantation rate (%) P-value
High-volume centre 12.0 0.457
Diabetes mellitus 22.0 0.824
Postprostatectomy incontinence 11.8 0.323
Pelvic radiation 18.3 0.148
Salvage surgery 14.0 0.701
Bladder neck stricture 25.9 0.040*
Urethral stricture 10.0 0.663
Intraoperative single-shot antibiotics 17.4 0.512
Intraoperative complications 16.7 0.525
Postoperative bleeding 18.2 0.638
Postoperative wound healing disorder 33.3 0.094
Postoperative urinary retention 17.9 0.377
Prolonged perineal pain 21.9 0.154
Postoperative infection 46.7 0.001*
*P<0.05, statistically significant.   
Time to explantation (day)
P=0.503
D
ev
ice
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l (
%
)
100
80
60
40
20
0
0 100 200 300 400 500 600
Adjustable male sling censored
AUS censored
AUS
Adjustable male sling
Fig. 1. Kaplan-Meier plot comparing device survival after ad-
justable male sling (blue line: median survival 130 days; 95% 
confidence interval [CI], 7–255) to AUS (red dots: median sur-
vival 101 days, 95% CI, 27–183) implantation. AUS, artificial 
urinary sphincter.
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wards increased explantation rates in the AUS subgroup (OR, 
2.615; P=0.074,).
DISCUSSION
Based on current therapy algorithms, the perineal single-cuff 
AUS is the gold standard in the treatment of moderate and se-
vere male SUI [2,4]. Adjustable male slings are currently of 
emerging interest in this patient group, but evidence regarding 
their use is still weak. In the current multi-institutional study, 
we compare perioperative safety as well as explantation rates of 
2 adjustable sling systems (Argus classic and Argus T) and the 
perineal single-cuff AMS 800 in a large, multi-institutional con-
temporary patient cohort. 
 To address differences in postoperative complication and de-
vice explantation rates in an adequately generalizable way, we 
focused on patients that have undergone surgery in a sufficient-
ly experienced incontinence center. 
 We found a significantly increased intraoperative complica-
tion rate during adjustable male sling implantation compared 
to AUS implantation. When performing a subgroup analysis of 
the adjustable male sling patient cohort, we found that the vast 
majority of intraoperative complications happened to be blad-
der perforations during Argus classic implantation. Addressing 
this topic, Bochove-Overgaauw and Schrier [13] analyzed the 
outcome after 100 Argus classic implantations and described 
bladder perforations in 6%. Considering the different surgical 
approaches, it seems intuitive that bladder perforations occur 
much less frequently during Argus T implantation [11].
 A statistical trend towards prolonged perineal pain in the ad-
justable male sling group could be observed. Further subgroup 
analysis revealed significantly increased postoperative perineal 
pain rates in the Argus T cohort. This is in line with previous 
prospective case series [11]. The explanation for higher postop-
erative perineal pain rates after transobturatoric male sling im-
plantation is supposed to be multifactorial, including neuro-
pathic pain. Since treatment of persistent perineal pain is often 
challenging, our findings highlight the importance of preopera-
tive patient information [11]. 
 In univariate analysis, device explantation rates were signifi-
cantly higher after AUS implantation compared to adjustable 
male sling implantation. Time-to-explantation did not vary sig-
nificantly. While considerable explantation rates after AUS im-
plantation have been reported previously, our results highlight 
the safety of the analyzed adjustable male slings [5]. However, 
AUS implantation could not be confirmed as an independent 
risk feature for device explantation in the current study and 
confounding factors such as experience of the implanting cen-
ter cannot be completely ruled out. 
 In line with previous results, urethral erosion was the most 
common reason for AUS explantation in our patient cohort [5]. 
Persistent SUI and device dislocation were the most frequent 
reasons for adjustable male sling explantation. The peripheric 
washers of the Argus T male sling dislocated in 2 cases, leading 
to ineffectiveness and inability to readjust properly. In 1 case, 
the perineal cushion of an Argus T sling dislocated laterally, 
and it eventually had to be explanted.
 A main finding of the current study is the analysis of features 
associated with device explantation rates. We found a more 
than 6 fold increased explantation risk after any kind of periop-
erative infection, such as UTI, epididymitis, or wound infec-
tions. Our results highlight the importance of avoidance of 
perioperative infections by the implanting team. 
 Our results indicate that a history of bladder neck stricture 
might have a moderate impact on device survival. Literature re-
garding treatment of male SUI and concomitant bladder neck 
stricture is currently limited to small case series [14]. Anger et 
al. [15] reported general feasibility of simultaneous stricture in-
cision and AUS implantation without stating the detailed func-
tional outcomes after the implantations. Mark et al. [16] report-
ed a social continence rate (no pads or one thin pad per day) of 
92% for patients with concomitant anastomotic stricture treated 
with AUS implantation.
 Evidence addressing risk factors for explantation after adjust-
able male sling implantation is still rare. Dalpiaz et al. [17] stud-
ied potential risk factors for general complication rates after Ar-
gus classic implantation and found no statistically significant 
impact of median age, comorbidity, incontinence grade, or pre-
vious pelvic irradiation. In contrast, Bochove-Overgaauw and 
Schrier [13] observed increased complication rates after Argus 
classic implantation in previously irradiated patients and pa-
tients with a history of urethral stricture disease. 
 In the current study, we provide evidence that the experience 
of the respective center might not be a major prognostic feature 
of device survival. Our cutoff value may be debatable. However, 
it is based on the contemporary caseload of 13 international 
continence centers. These findings are of the utmost clinical 
importance since in many parts of the world, including in Cen-
tral Europe, occasional implanters perform a majority of the in-
continence device implantations. 
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 Our study is not devoid of limitations. First and foremost are 
the limitations inherent to retrospective analyses. However, it 
remains unclear if the heterogeneity of the analyzed subgroups 
may have affected the outcome of our study to some degree. 
Due to its retrospective, multi-institutional design, patient selec-
tion and postoperative follow-up was not standardized in the 
current study. It is also unclear how the individual surgeon’s 
learning curve and experience may have affected the complica-
tion rates in our multicenter patient collective [18]. We focused 
on short-term complications within 6 months. It is therefore 
possible that long-term complication profiles may vary from the 
ones observed in this study. The Argus T subgroup was smaller 
than the Argus classic and AUS subgroup. The results of the 
current study must be confirmed in larger patient cohorts. 
 In summary, we observed different perioperative complica-
tion profiles for adjustable male slings and the perineal AUS. 
Postoperative infections are an independent predictive feature 
for decreased device survival. The experience of the implanting 
center did not correlate significantly with device explantation 
rates. This is the first comparative study that includes several 
devices in a large contemporary, multi-institutional patient co-
hort. We analyzed low-volume institutions separately and are 
therefore able to reflect the current standard of care for when 
occasional implanters perform the implantations.
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